(VRTX) Vertex Pharmaceuticals - Performance 24.1% in 12m
Compare VRTX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
58.41%
#8 in Group
Rel. Strength
78.44%
#1721 in Universe
Total Return 12m
24.05%
#39 in Group
Total Return 5y
88.47%
#22 in Group
P/E -
(?) Percentile in Group
P/E Forward 27.8
73th Percentile in Group
PEG 1.34
83th Percentile in Group
FCF Yield -0.65%
77th Percentile in Group
12m Total Return: VRTX (24.1%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: VRTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VRTX
Total Return (including Dividends) | VRTX | XBI | S&P 500 |
---|---|---|---|
1 Month | 2.91% | 5.55% | -0.45% |
3 Months | 6.06% | -9.75% | -6.29% |
12 Months | 24.05% | -5.39% | 13.04% |
5 Years | 88.47% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | VRTX | XBI | S&P 500 |
1 Month | 78.8% | 70% | 47.5% |
3 Months | 51.6% | -88.1% | -87.3% |
12 Months | 21.8% | -44.4% | 54.3% |
5 Years | 87.8% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #113 | -2.50% | 3.37% |
3 Month | #39 | 17.5% | 13.2% |
12 Month | #39 | 31.1% | 9.74% |
5 Years | #23 | 117% | -11.0% |
FAQs
Does VRTX Vertex Pharmaceuticals outperforms the market?
Yes,
over the last 12 months VRTX made 24.05%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months VRTX made 6.06%, while XBI made -9.75%.
Over the last 3 months VRTX made 6.06%, while XBI made -9.75%.
Performance Comparison VRTX vs Indeces and Sectors
VRTX vs. Indices VRTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.85% | 3.36% | 7.47% | 11.0% |
US NASDAQ 100 | QQQ | -1.77% | 1.01% | 6.76% | 9.08% |
US Dow Jones Industrial 30 | DIA | -0.31% | 5.76% | 8.23% | 14.8% |
German DAX 40 | DAX | -0.49% | 3.13% | -10.6% | -0.96% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.80% | 6.12% | 11.2% | 19.1% |
Hongkong Hang Seng | HSI | -0.45% | 4.43% | 6.94% | 11.1% |
India NIFTY 50 | INDA | 1.67% | -1.97% | 7.59% | 21.2% |
Brasil Bovespa | EWZ | 0.78% | 0.08% | 1.77% | 30.8% |
VRTX vs. Sectors VRTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -1.00% | 3.51% | 1.49% | 0.59% |
Consumer Discretionary | XLY | -0.88% | 3.50% | 6.30% | 9.38% |
Consumer Staples | XLP | 1.21% | 3.73% | 3.37% | 13.1% |
Energy | XLE | 3.41% | 17.0% | 12.6% | 33.4% |
Financial | XLF | 0.26% | 4.92% | 0.54% | 1.38% |
Health Care | XLV | 1.85% | 7.58% | 12.6% | 25.3% |
Industrial | XLI | -1.17% | 2.61% | 6.43% | 13.4% |
Materials | XLB | 0.96% | 6.13% | 15.3% | 28.5% |
Real Estate | XLRE | -0.74% | 4.01% | 7.31% | 5.69% |
Technology | XLK | -2.41% | 0.48% | 10.4% | 13.6% |
Utilities | XLU | 0.43% | 2.81% | 3.05% | 3.26% |
Aerospace & Defense | XAR | -1.88% | -4.07% | -6.41% | -3.43% |
Biotech | XBI | -0.69% | -2.64% | 22.8% | 29.4% |
Homebuilder | XHB | 0.42% | 4.99% | 22.4% | 30.2% |
Retail | XRT | 0.39% | 4.07% | 13.4% | 25.6% |